The Latest Cardiac and Vascular News
CLICHY, France–(BUSINESS WIRE)–CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO) in Hannover. Trevor Snyder, PhD, Senior Director, Translational and Clinical Research at CorWave, delivered an oral presentation, “CorWave […]
CLICHY, France–(BUSINESS WIRE)–CorWave announced today that results from chronic preclinical studies to evaluate its Left Ventricular Assist Device (LVAD) will be presented at the 65th Annual Conference of the American Society for Artificial Internal Organs (ASAIO) in San Francisco. The poster presentation, entitled “Low Shear, High Flow, and Physiologic Pulsatility: The CorWave LVAD”, is part […]
CLICHY, France–(BUSINESS WIRE)–The CALYPSO Research and Development (R&D) program, with a total budget of 25 million euros over 4 years, will be partially financed with 14 million euros support from the Programme d’Investissements d’Avenir (Future Investments Program), managed by the Secrétariat Général pour l’Investissement (General Secretariat for Investment – SGPI) and operated by Bpifrance. A breakthrough technology […]
CLICHY, France–(BUSINESS WIRE) CorWave, a French medical technology company that develops innovative implanted cardiac support devices for patients suffering from heart failure, announced today that it has been awarded almost $3.5 million in financing for its R&D program NovaPulse in the Silver Economy category. This is part of phase 2 of France’s Concours Mondial d’Innovation or Worldwide Innovation […]
